查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1963982

细菌菌落计数器市场 - 全球产业规模、份额、趋势、机会、预测：按类型、应用、最终用户、地区和竞争对手划分，2021-2031年

Bacterial Colony Counters Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球细菌菌落计数器市场预计将从 2025 年的 4.1587 亿美元成长到 2031 年的 5.6791 亿美元，复合年增长率达到 5.33%。

这些专用实验室仪器对于估算营养琼脂平板上活微生物（例如细菌和真菌）的数量至关重要。该市场的成长主要受以下因素驱动：对严格食品安全检测的需求日益增长，以及製药和化妆品行业实施的严格品管法规。此外，感染疾病控制所需的临床诊断量不断增加，也是推动产业成长的重要因素，确保了对不受短期技术潮流影响的、精确的微生物定量工具的稳定需求。

市场概览
预测期 2027-2031
市场规模：2025年 4.1587亿美元
市场规模：2031年 5.6791亿美元
复合年增长率：2026-2031年 5.33%
成长最快的细分市场 医疗保健
最大的市场 北美洲

儘管有这些成长趋势，但自动化计数系统高昂的购买和维修成本仍然是价格敏感型发展中地区采用该系统的一大障碍。关键的健康数据凸显了对经济实惠且准确的解决方案的迫切需求。世界卫生组织（世卫组织）指出，到2025年，全球六分之一的细菌感染疾病将对标准抗生素治疗产生抗药性，凸显了提高监测和检测能力的必要性。因此，儘管资金限制仍然是一个障碍，但加强全球健康监测的迫切需求将继续支撑市场稳定。

市场驱动因素

製药和生物技术行业的快速成长是全球细菌菌落计数器市场的主要驱动力。随着生物製药、疫苗和无菌注射剂产量的增加，对精确微生物限量检测的需求也随之增长，以确保产品安全性和符合法规要求。开发平臺的扩展直接转化为对用于微生物附着量评估的先进计数系统的采购量增加。根据国际药品製造商协会联合会（IFPMA）2024年7月发布的《製药业事实与数据》报告，全球有超过285种疫苗正在研发中，这些疫苗需要在临床试验和生产的每个阶段进行严格的微生物品管，以防止污染并确保疫苗的有效性。

同时，感染疾病和食源性病原体的日益传播对检测实验室提出了更高的检测能力要求。食品供应链中高污染率和抗药性菌株的出现，使得高效处理不断增长的检测量成为必要，因此需要高通量筛检解决方案。根据欧洲食品安全局 (EFSA) 于 2024 年 12 月发布的《2023 年一体化健康通用感染疾病报告》，2023 年欧盟确诊的沙门氏菌病病例同比增长 16.9%，凸显了健全的病原体监测系统的重要性。对诊断准确性日益增长的需求也反映在主要市场参与者的财务表现中。例如，生物梅里埃公司 (bioMerieux) 报告称，其微生物部门 2024 年的有机销售额增长了 8.7%，这主要得益于其试剂和仪器解决方案的持续普及。

市场挑战

自动化计数系统高昂的初始成本和营运成本是全球细菌菌落计数器市场扩张的主要障碍。虽然自动化设备相比人工计数方法具有更高的准确性和效率，但其高昂的初始投资要求使得许多中小实验室难以负担，尤其是在价格敏感的发展中地区。这一经济壁垒限制了市场渗透率，迫使预算紧张的机构继续依赖传统的、劳动密集的人工计数技术。因此，先进数位计数器的普及速度正在放缓，直接影响面向这些分散市场的製造商的产生收入。

日益收紧的报销机制进一步加剧了这种经济压力，限制了检查室的资本投资。当营运资金紧张时，设备升级往往是首先被推迟的项目。根据美国临床实验室协会 (ACLA) 预测，到 2024 年，整个产业约 800 项特定实验室服务的医疗保险支付金额预计将减少高达 15%。如此大幅度的报销削减迫使检查室管理者优先考虑必要的营运成本，而非购买新设备，因此，市场不得不继续依赖传统的低成本技术。这将限制自动化菌落计数产业的整体成长轨迹。

市场趋势

人工智慧 (AI) 和机器学习演算法的融合正在克服传统像素阈值方法的局限性，并革新菌落计数技术。现代系统利用深度学习神经网络，以前所未有的精确度从琼脂杂质和残留物中识别出活菌落，从而降低复杂基质中的假阳性率。随着检查室寻求规范判读流程并最大限度地减少品管过程中的人为误差，这项技术变革正在迅速普及。根据美国微生物学会 (ASM) 于 2025 年 3 月发布的《2024 年临床微生物学开放会议论文集》，目前仅有 17% 的临床检查室使用 AI 工具进行影像分析，但另有 31% 的实验室预计将在计画期结束时采用这些先进的演算法解决方案来提高诊断准确性。

同时，即时动态细菌生长监测技术的引入正在将工作流程从终点分析转变为连续观察。动态测量设备整合了培养和成像功能，能够检测微菌落出现的瞬间，与静态人工计数相比，显着缩短了获得关键无菌检测结果所需的时间。这种方法能够在生产环境中快速采取纠正措施，并产生符合严格监管资料完整性要求的可靠数位成长曲线。市场财务数据也表明，产业对这种自动化监测系统的依赖性日益增强。根据Rapid Micro Biosystems于2025年11月发布的2025年第三季财报，该公司经常性营收年增32%。这主要归功于其已部署的自动化监测系统耗材使用量创下历史新高。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：细菌菌落计数器的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型（自动、手动）
    • 按应用领域（医疗、检测设备、其他）
    • 按最终用户（製药和生物技术公司、临床检查室、其他）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美细菌菌落计数器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲细菌菌落计数器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区细菌菌落计数器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲细菌菌落计数器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲细菌菌落计数器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球细菌菌落计数器市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Instem Group of Companies
  • Thomas Scientific
  • Avantor
  • WIGGENS CO., LTD.
  • bioMerieux SA
  • Microbiology International
  • BioLogics, Inc.
  • Molecular Devices, LLC.
  • Daigger Scientific Inc.
  • Symbiosis

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 25347

The Global Bacterial Colony Counters Market is projected to expand from USD 415.87 Million in 2025 to USD 567.91 Million by 2031, achieving a CAGR of 5.33%. These specialized laboratory instruments are essential for estimating the count of viable microorganisms, such as bacteria and fungi, on nutrient agar plates. The market is primarily underpinned by the growing need for rigorous food safety inspections and the strict quality control regulations enforced within the pharmaceutical and cosmetic sectors. Additionally, the increasing volume of clinical diagnostics necessary for infectious disease management serves as a strong driver for industry growth, ensuring a consistent demand for accurate microbial quantification tools that operates independently of temporary technological fads.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 415.87 Million
Market Size 2031USD 567.91 Million
CAGR 2026-20315.33%
Fastest Growing SegmentMedical
Largest MarketNorth America

Despite this growth trajectory, the substantial acquisition and maintenance costs linked to automated counting systems create a significant hurdle to adoption in price-sensitive developing regions. The urgent need for affordable yet precise solutions is highlighted by critical health data. According to the World Health Organization, in 2025, one in six bacterial infections globally was reported as resistant to standard antibiotic treatments, underscoring the necessity for improved surveillance and testing capabilities. Consequently, while financial limitations remain an obstacle, the compelling requirement for enhanced global health monitoring continues to support market stability.

Market Driver

The rapid growth of the pharmaceutical and biotechnology sectors serves as a major catalyst for the Global Bacterial Colony Counters Market. As manufacturers increase the production of biologics, vaccines, and sterile injectables, the demand for precise microbial limit testing to guarantee product safety and regulatory compliance has intensified. This expansion in development pipelines leads directly to increased procurement of advanced counting systems for bioburden estimation. According to the International Federation of Pharmaceutical Manufacturers and Associations, in their July 2024 'Pharmaceutical Industry Facts & Figures' report, there were over 285 vaccines under development globally, a pipeline that demands strict microbiological quality control at every stage of clinical trial and manufacturing to prevent contamination and ensure efficacy.

Simultaneously, the rising prevalence of infectious diseases and foodborne pathogens is compelling laboratories to upgrade their detection capabilities. High rates of contamination in the food supply chain and outbreaks of resistant bacterial strains necessitate high-throughput screening solutions to handle increasing testing volumes efficiently. According to the European Food Safety Authority's December 2024 'European Union One Health 2023 Zoonoses Report', confirmed cases of Salmonellosis in the EU increased by 16.9% in 2023 compared to the previous year, highlighting the critical need for robust pathogen surveillance. This growing demand for diagnostic precision is reflected in the financial performance of key market players; for instance, bioMerieux reported an 8.7% organic sales growth in its microbiology segment in 2024, driven by the continued adoption of reagent and instrument solutions.

Market Challenge

The high acquisition and operational expenses associated with automated counting systems constitute a substantial impediment to the expansion of the Global Bacterial Colony Counters Market. While automated instruments offer superior precision and efficiency compared to manual methods, their initial capital requirements place them out of reach for many small-to-medium-sized laboratories, particularly in price-sensitive developing regions. This financial barrier limits market penetration, as facilities with restricted budgets are forced to continue relying on traditional, labor-intensive manual counting techniques. Consequently, the adoption rate of advanced digital counters slows, directly dampening revenue generation for manufacturers targeting these fragmented market segments.

This economic pressure is further exacerbated by tightening reimbursement structures that constrain laboratory capital expenditures. When operational funds are squeezed, equipment upgrades are often the first line item to be deferred. According to the American Clinical Laboratory Association, in 2024, the industry faced projected Medicare payment reductions of up to 15 percent for nearly 800 specific laboratory services. Such significant contractions in reimbursement levels compel laboratory administrators to prioritize essential operational costs over the procurement of new instrumentation, thereby sustaining the market's reliance on older, less expensive technologies and restricting the overall growth trajectory of the automated colony counter segment.

Market Trends

The integration of Artificial Intelligence and Machine Learning algorithms is reshaping colony counting by addressing the limitations of traditional pixel-thresholding methods. Modern systems utilize deep learning neural networks to distinguish viable microbial colonies from agar impurities or debris with unprecedented accuracy, thereby reducing false-positive rates in complex matrices. This technological shift is rapidly gaining traction as laboratories seek to standardize interpretation and minimize human error in quality control processes. According to the American Society for Microbiology, in the March 2025 'Proceedings of the Clinical Microbiology Open 2024' report, while only 17% of clinical laboratories had currently implemented AI tools for image analysis, an additional 31% anticipated adopting these advanced algorithmic solutions by the end of the planning period to enhance diagnostic precision.

Concurrently, the adoption of Real-Time Kinetic Bacterial Growth Monitoring is transforming the workflow from endpoint analysis to continuous observation. Kinetic instruments integrate incubation and imaging to detect micro-colonies the moment they appear, significantly accelerating time-to-result for critical sterility tests compared to static manual counting. This approach enables faster corrective actions in manufacturing environments and generates robust digital growth curves that satisfy stringent regulatory data integrity requirements. The escalating industrial reliance on this automated surveillance is evident in market financials; according to Rapid Micro Biosystems, in the November 2025 'Third Quarter 2025 Financial Results' report, the company recorded a 32% year-over-year increase in recurring revenue, attributed to the record volume of consumables utilized across its installed base of automated monitoring systems.

Key Market Players

  • Instem Group of Companies
  • Thomas Scientific
  • Avantor
  • WIGGENS CO., LTD.
  • bioMerieux SA
  • Microbiology International
  • BioLogics, Inc.
  • Molecular Devices, LLC.
  • Daigger Scientific Inc.
  • Symbiosis

Report Scope

In this report, the Global Bacterial Colony Counters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bacterial Colony Counters Market, By Type

  • Automatic Type
  • Manual Type

Bacterial Colony Counters Market, By Application

  • Medical
  • Testing Instruments
  • Others

Bacterial Colony Counters Market, By End User

  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories
  • Others

Bacterial Colony Counters Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bacterial Colony Counters Market.

Available Customizations:

Global Bacterial Colony Counters Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bacterial Colony Counters Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Automatic Type, Manual Type)
    • 5.2.2. By Application (Medical, Testing Instruments, Others)
    • 5.2.3. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Bacterial Colony Counters Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bacterial Colony Counters Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Bacterial Colony Counters Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Bacterial Colony Counters Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Bacterial Colony Counters Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bacterial Colony Counters Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Bacterial Colony Counters Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Bacterial Colony Counters Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Bacterial Colony Counters Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Bacterial Colony Counters Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Bacterial Colony Counters Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bacterial Colony Counters Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Bacterial Colony Counters Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Bacterial Colony Counters Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Bacterial Colony Counters Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Bacterial Colony Counters Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Bacterial Colony Counters Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bacterial Colony Counters Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Bacterial Colony Counters Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Bacterial Colony Counters Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Bacterial Colony Counters Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bacterial Colony Counters Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Bacterial Colony Counters Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Bacterial Colony Counters Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bacterial Colony Counters Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Instem Group of Companies
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thomas Scientific
  • 15.3. Avantor
  • 15.4. WIGGENS CO., LTD.
  • 15.5. bioMerieux SA
  • 15.6. Microbiology International
  • 15.7. BioLogics, Inc.
  • 15.8. Molecular Devices, LLC.
  • 15.9. Daigger Scientific Inc.
  • 15.10. Symbiosis

16. Strategic Recommendations

17. About Us & Disclaimer